1 / 30

GENEFLUX™ Biosciences

GENEFLUX™ Biosciences. (ISO9001:2008 Certified Company) (ISO17025:2005 Accreditated (ISO13485:2003 Certified laboratory facility). http://www.geneflux.net.my. Frost & Sullivan Award -2010 , for the Niche company in Molecular Diagnostics in Asia Pacific Region

oni
Download Presentation

GENEFLUX™ Biosciences

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. GENEFLUX™ Biosciences (ISO9001:2008 Certified Company) (ISO17025:2005 Accreditated (ISO13485:2003 Certified laboratory facility) http://www.geneflux.net.my Frost & Sullivan Award -2010, for the Niche company in Molecular Diagnostics in Asia Pacific Region Frost & Sullivan Award -2012, for the Southeast Asia Fastest Growing Company in Molecular Diagnostics for Infectious Disease

  2. Geneflux - background • Geneflux™ Biosciences Sdn. Bhd. is a privately held, research and technology driven biotechnology and molecular diagnostics company specialized in the manufacture of molecular diagnostic kits and providing services to healthcare industry. • Establishment: in the year 2007 in Malaysia and India • BioNexus Status Company Award: June 2008 • Geneflux™ Diagnostics Sdn. Bhd. is a wholly owned subsidiary of Geneflux Biosciences, dedicated to provide molecular diagnostic services in Malaysia. • Establishment: in the year 2009 in Malaysia

  3. Management • Board of Directors • Ir.Balaguru Naidu, Director & CEO • Dr.Prashanth G.Bagali, Director & COO, SVP • Mr. Azlan bin Baharom, Director • Mr. Mohammad Abdul Samad, Director • Business & Organizational Leaders • Ir.Balaguru Naidu, CEO • Dr.Prashanth G.Bagali, COO & SVP-Sci. and Tech.

  4. Company data • Authorized capital: RM500,000.00 • Issued capital: RM425,000.00 • Company #: 769382-V; Registration: April 13, 2007 • Registered address: 7-3 block ), Jalan Selingsing 3, Taman Sri Kuching, 51200, Kuala Lumpur, Malaysia • Business address: G1&G2, Menara KLH, Bandar Puchong Jaya, 47100 Puchong, Selangor DE, Malaysia • Telephone; +60-3-80701154; Fax: +60-3-80703654 • Email: info@geneflux.net.my, pgbagali@geneflux.net.my

  5. Certification & registrations • BioNexus Status Company Award: June 2008 • Certification under Malaysian Biotechnology Corporation • Achievement under Technofund scheme Ministry of Science, Technology and Innovation (MOSTI) – project grant and Award • Frost & Sullivan Award -2010, for the Niche company in Molecular Diagnostics in Asia Pacific Region • Frost & Sullivan Award -2012, for the Southeast Asia Fastest Growing Company in Molecular Diagnostics for Infectious Disease • Certification of ISO9001:2008 • Certification of ISO13485:2003 • Accreditation of ISO17025:2005 • RCPA Quality Assurance Program, Australia • Institute of Medical Research (IMR) Internal Quality Assessment Scheme, Malaysia • Registrations: MOF, MITI, MATRDE

  6. Global Presence *Geneflux Biosciences Private Limited, Bangalore *Geneflux Diagnostics Limited, London *Geneflux Biodiagnostics LLC, Detroit (USA) Total Staff: 19 • Science & Technology division: 8 • Admin, HR & Support Division: 5 • Sales, Marketing and Customer Support: 2 • Logistics and Operations Division: 4 * = independent companies

  7. Science & Technology team • Prashanth Bagali, PhD (Genetics), PhD (Biotech),PDF (NIH-NIDDK, USA) • Geetha Subramaniam, PhD (Med.Microbiology) • Parimala, BS (Biomedicine) • Pathma, BS (Biomedicine) • Ketan Kumar, BE (biotechnology) • Erwina [B.S (1st year ) in Biotechnology] • Nurfasha [B.S (1st year) in Biotechnology] • Lab. Assistants • Lab. Technicians

  8. PRODUCTS AND SERVICES SCIENCE & TECHNOLOGY Research Molecular Diagnostics Services Product Development Technologies Bacteria Viruses Product validation PCR Technology Projects Microarray Contract Research 2D & 3D Gels analysis Protein Profiling Training

  9. Core Technologies • Nucleic acid (DNA and RNA) based tests • Polymerase chain reaction (PCR) • Real time reverse transcriptase PCR (RT-PCR) • Microbiology lab tests • ELISA based tests • Rapid Antigen Tests

  10. Core Business • Manufacturing of molecular diagnostic kits • Providing diagnostic services to private and public hospitals, clinics and medical centres Geneflux Diagnostics Sdn. Bhd. is the wholly owned subsidiary of Geneflux Biosciences Sdn Bhd. Directors / shareholders: • Ir.Balaguru Naidu • Dr.Prashanth G.Bagali

  11. Diagnostics Laboratory • ISO9001:2008 certified quality management system • ISO17025:2005 (accreditation for “laboratory quality and proficiency ”) • ISO13485:2003 design, manufacturing and production of molecular diagnostic test kits and providing diagnostic services • 4000 sq.ft built-in area • Very well equipped to handle 1000 samples for PCR analysis everyday • Statutory and regulatory compliance to Biosafety and clinical waste disposal • Work bench capacity: simultaneously 14 persons can work • Total investment: 2.5 million ringgits (approx. US$750,000)

  12. Diagnostics Laboratory (contd…) • Highlights • Five room concept: • Sample processing room • Pre-PCR room • Post-PCR room • Lab bench room • Decontamination / instrument room: Ice maker, freezers, MilliQ water purification system, incubators, wash area

  13. Diagnostics Laboratory (contd…) • Molecular biology equipments • PCR machines (Biorad, Eppendorf, Qiagen) : 2 conventional PCR, 3 real time PCR • Class II biological safety cabinets: 2 • Freezers / fridges (Sanyo, Toshiba, Hitachi, Haier): 5 • MilliQ water purification system • Gel documentation (Alpha Imager): 1 • Centrifuges –minicentrifuges, high speed: 4 • Concentrator, autoclave, Ice maker and incubators • Others: Thermomixer, electrophoresis units, PCR workstations, ductless fume cabinet

  14. Collaborations - R & D • Research collaborators: • University of Malaya (UM) • Universiti Putra Malaysia (UPM) • Universiti Kebangsaan Malaysia (UKM) • University Technology Petronas (UTP) • Universiti Sains Malaysia (USM) • Malaysian Palm Oil Board (MPOB) • Patents / Innovation / Licenses: • 4 Licenses

  15. Market Need and demand

  16. Business strategy • Franchising • Scaling up of business operation • Acquisition • Strategic Alliance

  17. Investment for business expansion 1. Pathology Services (a) PCR tests: New tests will be included to the existing list of PCR tests (b) Genetic tests: Existing list of tests. Dedicated team of Sales executives for building awareness in other states outside KL and Selangor. (c) Microarray and Next generation based sequencing based diagnostic tests (d) Business relationship with IMR, HKL, Sungai Buloh Hospital and National Public Health to increase inflow of samples with a "unique profit sharing strategy".

  18. Investment for business expansion (contd.) 2. Clinical Research Services (a) CRO (Contract Research Outsourcing) to biotech and pharmaceutical companies (b) Analytical services customized to specific requirement

  19. Investment for business expansion (contd.) (3) Wellness Centre- based on the concept of predictive, preventive and personalized medicine. (a) Individual offerings: Examples are Age wise tests for wellness, Gender based test package, Smoker panels, Drug and alcohol rehab tests, (b) Corporate Offerings: Pre-employment packages, Annual health checkups (c) Occupational Health offerings

  20. Investment for business expansion (contd.) (4) Centre of Excellence (CoE) will participate in national and international quality assurance programs and schemes; to become National Reference Laboratory (a) CoE for Microbiology (b) CoE for Molecular Pathology (c) CoE for Cancer in collaboration with Merck or Roche or AstraZenaca or Sanofi Pharma to popularize Companion Diagnostics

  21. Investment for business expansion (contd.) (5) Research and Development (a) Medical Biotechnology with specific focus on diabetes, cancer, CVD and others (b) Agricultural Biotechnology with specific focus on medicinal plants (6) Dental pulp stem cell banking:

  22. Products & Services • Geneflux™ conventional PCR and RT-PCR based kits • MyDENKit™, detection and serotyping of dengue virus using SybrGreen probe based real time PCR • Chikungunya detection kit (lab use only) using conventional PCR • MuRSAFlux ™, identification of Methicillin resistance staphylococcus aureus (lab use only) • FluFinder-detection of H1N1 virus (lab use only)

  23. There is great market need and demand for PCR tests and opportunity in both public and private sectors. Geneflux has the technological expertise and right team to provide solution within the best TAT (turn around time) and at affordable price. There is money to be made!!!!

  24. Passion for Science & Science in Action At your service Thank You

  25. 1. Sample Receiving ROOM

  26. 2.Pre-PCR room

  27. 3.Post PCR room

More Related